Get the best experience on mobile
Join 5K+ users on Alpha Tribe
IBL's board has met and approved the financial results for the quarter and half-year. H1 consolidated net profit stood at ₹1.07 Cr. Director Ms. Lakshmiprabha Kasiraman also stepped down.
Comments
All announcements from Indrayani Biotech Ltd